Results 141 to 150 of about 739,236 (344)
FREQUENCY OF HYPONATREMIA, HYPOKALEMIA AND RENAL DYSFUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE
Muhammad Rehanul Haq +4 more
openalex +2 more sources
In PCOS patients with hyperandrogenemia, decreased ferritin heavy chain 1 (FTH1) causes Fe2⁺ overload and ferroptosis in trophoblasts. Androgens induce FTH1 protein degradation via AR‐LAMP2A‐mediated chaperone‐mediated autophagy pathway, leading to placental development disruption and early pregnancy loss. Metformin mitigates androgen‐induced placental
Hanjing Zhou +10 more
wiley +1 more source
A case of bismuth intoxication with irreversible renal damage
Abdulsamet Erden, Samet Karahan, Kadir Bulut, Mustafa Basak, Tuncay Aslan, Ali Cetinkaya, Hatice Karagoz, Deniz Avci Internal Medicine Department, Kayseri Training and Research Hospital, Kayseri, Turkey Abstract: Bismuth is a chemical element symbolized ...
Erden A +7 more
doaj
Acute renal failure with chronic lymphocytic leukaemia [PDF]
Alberto Martínez-Vea +6 more
openalex +1 more source
Targeting Adipose Tissue Function Protects Against Heart Failure with Preserved Ejection Fraction
This study explores the role adipose tissue (AT) phenotypes have in determining cardiovascular outcomes in an obesity‐related heart failure with preserved ejection fraction (HFpEF) model. Pharmacological induction of thermogenesis promoted resilience to HFpEF‐induced remodeling of AT and conferred cardioprotection. Surgical and genetic models confirmed
Jordan Jousma +11 more
wiley +1 more source
Comment on Cisplatin-Induced Renal Impairment [PDF]
Seyed Majid Mousavi Movahhed +2 more
doaj +1 more source
Chronic renal failure is a progressive and irreversible renal function disorder in which the body's ability to fail to maintain metabolism, fluid and electrolyte balance.
Saftia Aryzki +5 more
doaj
PDAC has a poor prognosis due to chemoresistance. We revealed that MCU upregulation is associated with chemoresistance and stemness in PDAC. MCU‐mediated Ca2+ influx induced ER stress, activating the PERK‐ATF4/NRF2 axis to enhance PSAT1/SLC711 expression and glutathione synthesis, reducing ROS and maintaining stemness.
Zekun Li +17 more
wiley +1 more source

